Rare diseases – an evolving medical communications landscape

A disease is considered rare when it affects fewer than 1 in 2,000 people. However, more than 6,000 rare diseases have been identified, and collectively they affect…

Read More

The return of our ‘boomerang’ employees

In the ever-evolving world of healthcare and medical communications, attracting and retaining top talent is an ongoing challenge. Among the many stories of career…

Read More

Liquid biopsies for earlier detection of recurrent endometrial tumours

Endometrial cancer affects many thousands of women across the globe. The early detection of recurrent endometrial cancer is crucial as it can directly impact patient…

Read More

Understanding the brain in pain modulation

Pain, a universal human experience, serves as a distress signal from the body, alerting us to potential injury or harm. While the perception of pain originates in our sensory…

Read More

Stem cell research in diabetes treatment

Biomedical research is of paramount importance as it fuels scientific progress and pushes the boundaries of knowledge in understanding human health and disease.

Read More

Mental health treatment gap

In recent years, there has been an increasing focus on the importance of mental health and its impact on overall well-being.

Read More

Intelligent cell division

At nspm, we understand the importance of knowledge and of delivering accurate medical information to healthcare professionals, patients, and anyone interested in staying…

Read More

nspm strengthens offer with sister company merger

We are excited to announce that, as of 1 December 2022, medcept and its sister company, nspm, have merged, and will in future operate as one company under the name nspm.

Read More